CardioPhoenix
Cardio-Phoenix, established in 2005, specializes in AI-powered technology for the non-invasive, early detection of heart diseases. Their core product, Cardio-HART (CHART), is a breakthrough cardiac diagnostic system that combines the functionality of an ECHO, ECG, and Auscultation into a single device, utilizing AI and novel bio-signals. CHART offers significantly higher detection rates (93%) for common heart diseases compared to ECG alone (44%), and it fits seamlessly into the standard of care. It aims to minimize unnecessary referrals and reduce wait times in primary care settings, enabling faster diagnosis for conditions like Heart Failure and Heart Valve diseases. The company's mission is to provide effective, affordable, and accessible heart care for all. Marc Bisnaire is the CEO and Founder.
CardioPhoenix
Cardio-Phoenix, established in 2005, specializes in AI-powered technology for the non-invasive, early detection of heart diseases. Their core product, Cardio-HART (CHART), is a breakthrough cardiac diagnostic system that combines the functionality of an ECHO, ECG, and Auscultation into a single device, utilizing AI and novel bio-signals. CHART offers significantly higher detection rates (93%) for common heart diseases compared to ECG alone (44%), and it fits seamlessly into the standard of care. It aims to minimize unnecessary referrals and reduce wait times in primary care settings, enabling faster diagnosis for conditions like Heart Failure and Heart Valve diseases. The company's mission is to provide effective, affordable, and accessible heart care for all. Marc Bisnaire is the CEO and Founder.